Is Streamline Health Stock a Good Investment?
Streamline Health Investment Advice | STRM |
- Examine Streamline Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Streamline Health's leadership team and their track record. Good management can help Streamline Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Technology space and any emerging trends that could impact Streamline Health's business and its evolving consumer preferences.
- Compare Streamline Health's performance and market position to its competitors. Analyze how Streamline Health is positioned in terms of product offerings, innovation, and market share.
- Check if Streamline Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Streamline Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Streamline Health Solutions stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Streamline Health Solutions is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Streamline Health Stock
Researching Streamline Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 24.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.96. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Streamline Health has Price/Earnings (P/E) ratio of 321.67. The entity recorded a loss per share of 2.35. The firm last dividend was issued on the 30th of September 2010. Streamline Health had 1:15 split on the 4th of October 2024.
To determine if Streamline Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Streamline Health's research are outlined below:
| Streamline Health generated a negative expected return over the last 90 days | |
| Streamline Health has high historical volatility and very poor performance | |
| Streamline Health has high likelihood to experience some financial distress in the next 2 years | |
| Streamline Health Solutions currently holds 10.57 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Streamline Health has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Streamline Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.6 M. Net Loss for the year was (18.7 M) with profit before overhead, payroll, taxes, and interest of 11.49 M. | |
| Streamline Health Solutions currently holds about 5.92 M in cash with (2.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Streamline Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 24.0% of Streamline Health outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Streamline Health Solutions, Inc. Sees Significant Increase in Short Interest |
Streamline Health Quarterly Cash And Short Term Investments |
|
Streamline Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Streamline Health Solutions. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Streamline Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 24th of April 2024 Upcoming Quarterly Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Streamline Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Streamline Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-09-11 | 2024-07-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2024-06-11 | 2024-04-30 | -0.04 | -0.05 | -0.01 | 25 | ||
2023-09-13 | 2023-07-31 | -0.05 | -0.04 | 0.01 | 20 | ||
2023-04-26 | 2023-01-31 | -0.05 | -0.04 | 0.01 | 20 | ||
2022-12-14 | 2022-10-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2022-06-08 | 2022-04-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2021-04-21 | 2021-01-31 | -0.06 | -0.05 | 0.01 | 16 | ||
2020-09-09 | 2020-07-31 | -0.05 | -0.04 | 0.01 | 20 |
Know Streamline Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Streamline Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Streamline Health Solutions backward and forwards among themselves. Streamline Health's institutional investor refers to the entity that pools money to purchase Streamline Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2024-12-31 | 1.1 K | Cwm, Llc Duplicate | 2024-12-31 | 86.0 | Jpmorgan Chase & Co | 2024-12-31 | 6.0 | Bank Of America Corp | 2024-12-31 | 2.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Overbrook Management Corp | 2024-09-30 | 0.0 | Herald Investment Management Ltd | 2024-09-30 | 0.0 | Hightower Advisors, Llc | 2024-09-30 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Harbert Fund Advisors Inc | 2024-12-31 | 321.6 K | Vanguard Group Inc | 2024-12-31 | 111.3 K |
Streamline Health's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.34 M.Market Cap |
|
Streamline Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.03) | (1.93) | |
| Return On Capital Employed | (0.81) | (0.77) | |
| Return On Assets | (0.52) | (0.49) | |
| Return On Equity | (0.89) | (0.85) |
Determining Streamline Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Streamline Health is a good buy. For example, gross profit margin measures Streamline Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Streamline Health's profitability and make more informed investment decisions.
Evaluate Streamline Health's management efficiency
Streamline Health has return on total asset (ROA) of (0.1054) % which means that it has lost $0.1054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8009) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of March 2025, Return On Tangible Assets is likely to grow to -1.93. In addition to that, Return On Capital Employed is likely to grow to -0.77. At this time, Streamline Health's Total Current Assets are very stable compared to the past year. As of the 28th of March 2025, Fixed Asset Turnover is likely to grow to 242.65, while Non Current Assets Total are likely to drop about 19.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.49 | 4.72 | |
| Tangible Book Value Per Share | (3.76) | (3.58) | |
| Enterprise Value Over EBITDA | (2.07) | (2.17) | |
| Price Book Value Ratio | 1.35 | 1.28 | |
| Enterprise Value Multiple | (2.07) | (2.17) | |
| Price Fair Value | 1.35 | 1.28 | |
| Enterprise Value | 26.5 M | 25.1 M |
The strategic initiatives led by Streamline Health's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 1.642 |
Basic technical analysis of Streamline Stock
As of the 28th of March, Streamline Health has the Coefficient Of Variation of 5171.13, risk adjusted performance of 0.0241, and Semi Deviation of 3.77. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Streamline Health, as well as the relationship between them. Please validate Streamline Health information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Streamline Health is priced more or less accurately, providing market reflects its prevalent price of 3.14 per share. Given that Streamline Health has jensen alpha of 0.1031, we advise you to double-check Streamline Health Solutions's current market performance to make sure the company can sustain itself at a future point.Streamline Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Streamline Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Streamline Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Streamline Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Streamline Health's Outstanding Corporate Bonds
Streamline Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Streamline Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Streamline bonds can be classified according to their maturity, which is the date when Streamline Health Solutions has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Streamline Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Streamline Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0241 | |||
| Market Risk Adjusted Performance | 0.0699 | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.77 | |||
| Downside Deviation | 4.09 | |||
| Coefficient Of Variation | 5171.13 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.99 | |||
| Information Ratio | 0.0231 | |||
| Jensen Alpha | 0.1031 | |||
| Total Risk Alpha | 0.2034 | |||
| Sortino Ratio | 0.0239 | |||
| Treynor Ratio | 0.0599 | |||
| Maximum Drawdown | 26.35 | |||
| Value At Risk | (6.72) | |||
| Potential Upside | 6.98 | |||
| Downside Variance | 16.72 | |||
| Semi Variance | 14.18 | |||
| Expected Short fall | (3.23) | |||
| Skewness | 0.8601 | |||
| Kurtosis | 3.42 |
| Risk Adjusted Performance | 0.0241 | |||
| Market Risk Adjusted Performance | 0.0699 | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.77 | |||
| Downside Deviation | 4.09 | |||
| Coefficient Of Variation | 5171.13 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.99 | |||
| Information Ratio | 0.0231 | |||
| Jensen Alpha | 0.1031 | |||
| Total Risk Alpha | 0.2034 | |||
| Sortino Ratio | 0.0239 | |||
| Treynor Ratio | 0.0599 | |||
| Maximum Drawdown | 26.35 | |||
| Value At Risk | (6.72) | |||
| Potential Upside | 6.98 | |||
| Downside Variance | 16.72 | |||
| Semi Variance | 14.18 | |||
| Expected Short fall | (3.23) | |||
| Skewness | 0.8601 | |||
| Kurtosis | 3.42 |
Consider Streamline Health's intraday indicators
Streamline Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Streamline Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Streamline Health Corporate Filings
10Q | 20th of December 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 16th of December 2024 Other Reports | ViewVerify | |
| 22nd of November 2024 Other Reports | ViewVerify | |
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Streamline Stock media impact
Far too much social signal, news, headlines, and media speculation about Streamline Health that are available to investors today. That information is available publicly through Streamline media outlets and privately through word of mouth or via Streamline internal channels. However, regardless of the origin, that massive amount of Streamline data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Streamline Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Streamline Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Streamline Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Streamline Health alpha.
Streamline Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Streamline Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Streamline Health Corporate Management
| Ben Stilwill | President | Profile | |
| Donald Vick | Director Analytics | Profile | |
| Bryant Reeves | Interim Staff | Profile | |
| Lance Seach | Senior Development | Profile | |
| Jawad Shaikh | Chief Officer | Profile | |
| Benjamin Stilwill | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (2.35) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Streamline Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.